Skip to content
    New Leaf Venture Partners logo

    New Leaf Venture Partners

    New York, New York, United StatesFounded 2005

    New Leaf Venture Partners is a venture capital firm focused exclusively on healthcare technology, investing across biopharmaceuticals, medical devices, molecular diagnostics, and healthcare IT. Founded in 2005 as a healthcare spinoff from the Sprout Group, the firm partners with companies from early-stage through public offerings.

    Deal activity increased 50% year-over-year (3 deals in the last 12 months). Average disclosed round size is $48.4M (across 92 rounds with reported amounts).

    Find people at New Leaf Venture Partners on Goldilocks AI

    Portfolio

    66

    Fund Size

    —

    Top Stage

    Series C

    Last 12 Mo

    3

    Team

    Vijay Lathi

    Vijay Lathi

    Co-Founder/Managing Director Menlo Park

    Ron Hunt

    Ron Hunt

    Managing Director

    Anthony Ford

    Anthony Ford

    Biopharmaceuticals Menlo Park

    Craig Slutzkin

    Craig Slutzkin

    Chief Operating Officer / Chief Financial Officer New York

    JN

    James Niedel

    Managing Director

    RS

    Ramesh Subramani

    Associate

    KL

    Kathy LaPorte

    Cofounder

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    92 investments
    CompanyRoundAmountDate
    BrightInsight logoBrightInsightUnknown$13MJan 2026
    Electra logoElectraSeries C$183MOct 2025
    EElectra TherapeuticsSeries C$183MOct 2025
    Abcuro, Inc. logoAbcuro, Inc.Series C$200MFeb 2025
    Star Therapeutics logoStar TherapeuticsSeries D$125MJan 2025
    EElectra TherapeuticsSeries B$84MJan 2025
    Aureka Biotechnologies logoAureka BiotechnologiesSeries A$100MJan 2025
    Cleerly logoCleerlySeries C$106MDec 2024
    Neurava logoNeuravaSeed$2.3MApr 2024
    Flosonics logoFlosonicsSeries C$20MMar 2024
    Flosonics logoFlosonicsSeries C$20MJan 2024
    Deciphera Pharmaceuticals logoDeciphera PharmaceuticalsSeries C$52MJan 2023
    Arine logoArineSeries B$29MAug 2022
    EElectra TherapeuticsSeries B$84MFeb 2022
    CCleerly CoronarySeries B$43MJun 2021
    AAkili, Inc.Series D$110.0MMay 2021
    AAkili, Inc.Series D$110MJan 2021
    Edgewise Therapeutics logoEdgewise TherapeuticsSeries B$50MSep 2019
    Renovacor logoRenovacorSeries A$11MJan 2019
    RRenovacorSeries A$11MJan 2019
    Renovacor logoRenovacorSeries A$11MJan 2019
    AiCure logoAiCureSeries C$56MJan 2019
    ReViral logoReViralSeries C$44MAug 2018
    Rallybio logoRallybioSeries A$37MApr 2018
    Arvinas logoArvinasSeries C$55MApr 2018
    Page 1 of 4

    Top Co-Investors

    Last updated: 7 October 2026